Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens

Proteogenomic Analysis of Human Colon Carcinoma Cell Lines LIM1215, LIM1899, and LIM2405

(2013) Susan Fanayan et al.   JOURNAL OF PROTEOME RESEARCH

Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes

(2012) Rui Chen et al.   CELL

Potential tumor markers of renal cell carcinoma: α-Enolase for postoperative follow up, and galectin-1 and galectin-3 for primary detection

(2012) Naoki Kaneko et al.   INTERNATIONAL JOURNAL OF UROLOGY

The Specificity of Urinary Aquaporin 1 and Perilipin 2 to Screen for Renal Cell Carcinoma

(2012) Jeremiah J. Morrissey et al.   JOURNAL OF UROLOGY

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

(2012) Steffen Walter et al.   NATURE MEDICINE

Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum

(2012) T. Shi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry

(2012) Regine M. Schoenherr et al.   PROTEOMICS

A proteogenomic approach to map the proteome of an unsequenced pathogen - Leishmania donovani

(2012) Harsh Pawar et al.   PROTEOMICS

Promise of personalized omics to precision medicine

(2012) Rui Chen et al.   Wiley Interdisciplinary Reviews-Systems Biology and Medicine

Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma

(2011) P. Kamper et al.   BLOOD

Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma

(2011) Angelika Tölle et al.   BMC CANCER

Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma

(2011) Eric Kuhn et al.   MOLECULAR & CELLULAR PROTEOMICS

A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease

(2011) Terri A Addona et al.   NATURE BIOTECHNOLOGY

Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer

(2011) Samir M. Hanash et al.   Nature Reviews Clinical Oncology

Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations

(2011) S Floor et al.   ONCOGENE

A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses

(2011) Matthew P. Welberry Smith et al.   PROTEOMICS

Combined Blood/Tissue Analysis for Cancer Biomarker Discovery: Application to Renal Cell Carcinoma

(2010) Donald J. Johann et al.   ANALYTICAL CHEMISTRY

Restructuring proteomics through verification

(2010) Emily Boja et al.   Biomarkers in Medicine

The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers

(2010) Z. Zhang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

High-abundance protein depletion: Comparison of methods for human plasma biomarker discovery

(2010) Veronika Polaskova et al.   ELECTROPHORESIS

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

(2010) Daniel D. Von Hoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics

(2010) Chengjian Tu et al.   JOURNAL OF PROTEOME RESEARCH

Plasma Proteome Response to Severe Burn Injury Revealed by18O-Labeled “Universal” Reference-Based Quantitative Proteomics

(2010) Wei-Jun Qian et al.   JOURNAL OF PROTEOME RESEARCH

Evolution of Clinical Proteomics and its Role in Medicine

(2010) Emily Boja et al.   JOURNAL OF PROTEOME RESEARCH

On the Development of Plasma Protein Biomarkers

(2010) Silvia Surinova et al.   JOURNAL OF PROTEOME RESEARCH

Sample complexity reduction aids efficient detection of low-abundant proteins from human amniotic fluid

(2010) Mashkoor Alam et al.   JOURNAL OF SEPARATION SCIENCE

Urinary Biomarkers for the Early Diagnosis of Kidney Cancer

(2010) Jeremiah J. Morrissey et al.   MAYO CLINIC PROCEEDINGS

Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis

(2010) Beate K Straub et al.   MODERN PATHOLOGY

Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma

(2010) Han W. Tun et al.   PLoS One

Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?

(2009) Angelika Tölle et al.   BMC CANCER

Mass spectrometry-based clinical proteomics profiling: current status and future directions

(2009) Peter Findeisen et al.   Expert Review of Proteomics

Approaching Solid Tumor Heterogeneity on a Cellular Basis by Tissue Proteomics Using Laser Capture Microdissection and Biological Mass Spectrometry†

(2009) Donald J. Johann et al.   JOURNAL OF PROTEOME RESEARCH

Equivalence of Protein Inventories Obtained from Formalin-fixed Paraffin-embedded and Frozen Tissue in Multidimensional Liquid Chromatography-Tandem Mass Spectrometry Shotgun Proteomic Analysis

(2009) Robert W. Sprung et al.   MOLECULAR & CELLULAR PROTEOMICS

Protein Depletion Using IgY from Chickens Immunised with Human Protein Cocktails

(2009) Antonio Rajic et al.   PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

Involvement of Members of the Cadherin Superfamily in Cancer

(2009) G. Berx et al.   Cold Spring Harbor Perspectives in Biology

Combinatorial hexapeptide ligand libraries (ProteoMiner™): An innovative fractionation tool for differential quantitative clinical proteomics

(2009) Sonja Hartwig et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Hexapeptide combinatorial ligand libraries: the march for the detection of the low-abundance proteome continues

(2008) Egisto Boschetti et al.   BIOTECHNIQUES

Proteomic Analysis of Laser-Captured Paraffin-Embedded Tissues: A Molecular Portrait of Head and Neck Cancer Progression

(2008) V. Patel et al.   CLINICAL CANCER RESEARCH

Evaluation of Three Principally Different Intact Protein Prefractionation Methods for Plasma Biomarker Discovery

(2008) Maria Pernemalm et al.   JOURNAL OF PROTEOME RESEARCH

Predictive validity of animal pain models? A comparison of the pharmacokinetic–pharmacodynamic relationship for pain drugs in rats and humans

(2008) G.T. Whiteside et al.   NEUROPHARMACOLOGY

Precision proteomics: The case for high resolution and high mass accuracy

(2008) M. Mann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

(2008) Vathany Kulasingam et al.   Nature clinical practice. Oncology